These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2924073)

  • 1. 1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction.
    Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1989 Jan; 96(1):211-9. PubMed ID: 2924073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines.
    Sebastião AM; Stone TW; Ribeiro JA
    Br J Pharmacol; 1990 Oct; 101(2):453-9. PubMed ID: 2257444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparent affinity of some 8-phenyl-substituted xanthines at adenosine receptors in guinea-pig aorta and atria.
    Collis MG; Jacobson KA; Tomkins DM
    Br J Pharmacol; 1987 Sep; 92(1):69-75. PubMed ID: 3664093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction.
    Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1988 May; 94(1):109-20. PubMed ID: 2456805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the high affinity of 8-cyclohexylcaffeine for the presynaptic inhibitory adenosine receptor present in rat motor nerve terminals.
    Lobo MG; Oliveira DG; Sebastião AM; Ribeiro JA
    Pharmacol Toxicol; 1997 Jun; 80(6):295-300. PubMed ID: 9225367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of adenosine-induced relaxation by methylxanthines in coronary artery.
    Ramagopal MV; Rash VA; Mustafa SJ
    Arch Int Pharmacodyn Ther; 1988; 295():174-80. PubMed ID: 3245733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the high affinity binding site for [3H]-1,3-dipropyl-8-cyclopentylxanthine in frog brain membranes.
    Oliveira JC; Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1993 Jun; 109(2):518-23. PubMed ID: 8358551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve ending of the rat.
    Correia-de-Sá P; Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1991 Jun; 103(2):1614-20. PubMed ID: 1679362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that a novel 8-phenyl-substituted xanthine derivative is a cardioselective adenosine receptor antagonist in vivo.
    Fredholm BB; Jacobson KA; Jonzon B; Kirk KL; Li YO; Daly JW
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):396-400. PubMed ID: 2438501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the type of receptor involved in the inhibitory action of adenosine at the neuromuscular junction.
    Ribeiro JA; Sebastião AM
    Br J Pharmacol; 1985 Apr; 84(4):911-8. PubMed ID: 2988684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction.
    Ribeiro JA; Sebastião AM
    J Physiol; 1987 Mar; 384():571-85. PubMed ID: 2821240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine depresses spontaneous transmitter release from frog motor nerve terminals by acting at an A1-like receptor.
    Barry SR
    Life Sci; 1990; 46(19):1389-97. PubMed ID: 2345486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.
    Schwabe U; Ukena D; Lohse MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):212-21. PubMed ID: 2997628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic A1-purinoceptor-mediated inhibitory effects of adenosine and its stable analogues on the mouse hemidiaphragm preparation.
    Nagano O; Földes FF; Nakatsuka H; Reich D; Ohta Y; Sperlagh B; Vizi ES
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):197-202. PubMed ID: 1333058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominance of adenosine excitatory over inhibitory effects on transmission at the neuromuscular junction of infant rats.
    Pousinha PA; Correia AM; Sebastião AM; Ribeiro JA
    J Pharmacol Exp Ther; 2010 Jan; 332(1):153-63. PubMed ID: 19789361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.
    Martinson EA; Johnson RA; Wells JN
    Mol Pharmacol; 1987 Mar; 31(3):247-52. PubMed ID: 3561384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between binding affinities for brain A1 and A2 receptors of adenosine agonists and antagonists and their effects on heart rate and coronary vascular tone.
    Oei HH; Ghai GR; Zoganas HC; Stone GA; Zimmerman MB; Field FP; Williams M
    J Pharmacol Exp Ther; 1988 Dec; 247(3):882-8. PubMed ID: 2849674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
    Daly JW; Padgett W; Shamim MT; Butts-Lamb P; Waters J
    J Med Chem; 1985 Apr; 28(4):487-92. PubMed ID: 2984420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of adenosine A2 receptor in PC12 cells.
    Noronha-Blob L; Marshall RP; Kinnier WJ; U'Prichard DC
    Life Sci; 1986 Sep; 39(12):1059-67. PubMed ID: 3018408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes.
    Ukena D; Schudt C; Sybrecht GW
    Biochem Pharmacol; 1993 Feb; 45(4):847-51. PubMed ID: 7680859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.